Home LiteratureArticle Details
PMID: 3108447 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

The Journal of experimental medicine ·Vol. 165 ·No. 6 ·1987-06-01 ·Pages 1581-94

Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G

Abstract

We present evidence that human peripheral blood lymphocytes, free of contaminating monocytes, rapidly produce high levels of tumor necrosis factor (TNF) when stimulated with phorbol diester and calcium ionophore, and lower but significant levels of TNF when stimulated with mitogens. These two types of inducers act preferentially on T cells, both CD4+ and CD8+. NK cells produce TNF only when stimulated with phorbol diester and calcium ionophore, and they do so at a much lower level than T cells. The procedures used in the purification of lymphocytes and the differential ability to respond to various inducers allow us to exclude that monocytes or basophils contaminating the lymphocyte preparation participate in the production of TNF. In particular, LPS, a potent inducer of TNF production from monocytes, is unable to induce significant levels of TNF in the lymphocyte preparations. The TNF produced by lymphocytes has antigenic, physicochemical, and biochemical characteristics identical to those of the TNF produced by myeloid cell lines or monocytes upon stimulation with LPS. LT is also produced by lymphocyte preparations. Production of TNF and LT proteins in response to the different inducers is paralleled by accumulation of cytoplasmic TNF and LT mRNA. Both at mRNA and at protein levels, stimulation of T lymphocytes with phorbol diester and calcium ionophore preferentially induces TNF, whereas mitogen stimulation preferentially induces LT. Our data suggest that the TNF and LT genes, two closely linked genes encoding two partially homologous proteins with almost identical biological functions, are independently regulated in lymphocytes.

MeSH Terms
Calcimycin/pharmacology Glycoproteins/biosynthesis,genetics Humans Interferon-gamma/pharmacology Killer Cells, Natural/metabolism Lipopolysaccharides/pharmacology Lymphocytes/classification,metabolism Lymphotoxin-alpha/biosynthesis,genetics Monocytes/metabolism Phorbol 12,13-Dibutyrate Phorbol Esters/pharmacology Phytohemagglutinins/pharmacology RNA, Messenger/analysis Transcription, Genetic Tumor Necrosis Factor-alpha
Chemicals
Glycoproteins Lipopolysaccharides Lymphotoxin-alpha Phorbol Esters Phytohemagglutinins RNA, Messenger Tumor Necrosis Factor-alpha Phorbol 12,13-Dibutyrate Calcimycin Interferon-gamma
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Cuturi M C
Murphy M
Costa-Giomi M P
Weinmann R
Perussia B
Trinchieri G
References (37)
37 references, click to expand
  1. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.
    J Exp Med. 1968 Dec 1;128(6):1267-79 PMID: 5693925
  2. An endotoxin-induced serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 PMID: 1103152
  3. The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters.
    J Immunol Methods. 1976;10(1):61-6 PMID: 1254974
  4. Monoclonal antibodies defining distinctive human T cell surface antigens.
    Science. 1979 Oct 19;206(4416):347-9 PMID: 314668
  5. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  6. Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells.
    Blood. 1982 Feb;59(2):382-92 PMID: 7055645
  7. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    J Immunol. 1982 Jul;129(1):433-9 PMID: 7086139
  8. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    J Immunol. 1983 May;130(5):2133-41 PMID: 6833758
  9. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.
    J Immunol. 1983 May;130(5):2142-8 PMID: 6339622
  10. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.
    J Biol Chem. 1984 Jan 10;259(1):686-91 PMID: 6608523
  11. Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro.
    J Biol Response Mod. 1984;3(1):76-87 PMID: 6608577
  12. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    J Immunol. 1984 Oct;133(4):1869-77 PMID: 6432902
  13. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  14. Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens.
    J Immunol. 1985 Feb;134(2):718-27 PMID: 3917474
  15. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):721-4 PMID: 6334807
  16. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
  17. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.
    J Biol Chem. 1985 Feb 25;260(4):2334-44 PMID: 3882692
  18. Molecular cloning of the complementary DNA for human tumor necrosis factor.
    Science. 1985 Apr 12;228(4696):149-54 PMID: 3856324
  19. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
    J Immunol. 1985 Sep;135(3):2069-73 PMID: 3926894
  20. Tumor necrosis factor (TNF).
    Science. 1985 Nov 8;230(4726):630-2 PMID: 2413547
  21. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    J Exp Med. 1985 Nov 1;162(5):1512-30 PMID: 3932579
  22. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Science. 1985 Nov 22;230(4728):943-5 PMID: 3933111
  23. Regulation of expression of the human interferon gamma gene.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):8173-7 PMID: 3934669
  24. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.
    J Exp Med. 1986 Mar 1;163(3):632-43 PMID: 3512757
  25. Tumor necrosis factor induction by Sendai virus.
    J Immunol. 1986 Apr 15;136(8):2938-42 PMID: 3007608
  26. Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.
    Cell. 1986 Jun 6;45(5):659-66 PMID: 2871942
  27. Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.
    J Exp Med. 1986 Jul 1;164(1):263-79 PMID: 3088195
  28. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
    J Immunol. 1986 Sep 15;137(6):1878-84 PMID: 2943806
  29. The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.
    J Immunol. 1986 Sep 15;137(6):1885-92 PMID: 2427583
  30. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
    J Immunol. 1986 Sep 15;137(6):1893-6 PMID: 3091693
  31. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    J Immunol. 1986 Oct 15;137(8):2592-8 PMID: 3760569
  32. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator.
    J Immunol. 1986 Nov 1;137(9):2774-83 PMID: 2428873
  33. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    J Immunol. 1986 Nov 1;137(9):2857-63 PMID: 3093586
  34. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.
    J Exp Med. 1986 Oct 1;164(4):1206-25 PMID: 3093627
  35. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
    J Exp Med. 1986 Oct 1;164(4):1350-5 PMID: 3020152
  36. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.
    Proc Natl Acad Sci U S A. 1986 Nov;83(22):8699-702 PMID: 3464978
  37. Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor.
    J Immunol. 1987 Feb 1;138(3):765-74 PMID: 3100615
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1987-06-01
Pages
1581-94
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188372
Subset
IM
Grants
NCI NIH HHS · CA 10815 · United States
NCI NIH HHS · CA 20833 · United States
NCI NIH HHS · CA 21124 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com